探索診斷DGX
紐約證券 · USD
233.01
-1.29
(-0.55%)
收盤 08/01 03:59 (UTC+8)
08/01 03:59 (UTC+8)
探索診斷DGX
233.01
-1.29
(-0.55%)
財務數據
損益表
- 23.66
- 23.97
- 24.88
- 26.21
- 26.52
- 27.61
- 28.16
- 28.06
- 28.95
- 30.43
- 3.41
- 1.31
- 3.80
- 5.35
- 1.18
- 4.11
- 1.99
- -0.36
- 3.17
- 5.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 3,043,000 | 2,895,000 | 2,806,000 | 2,816,000 | 2,761,000 | 2,652,000 | 2,621,000 | 2,488,000 | 2,397,000 | 2,366,000 |
營業成本 | 2,016,000 | 1,953,000 | 1,896,000 | 1,867,000 | 1,818,000 | 1,789,000 | 1,763,000 | 1,677,000 | 1,593,000 | 1,595,000 |
營業毛利 | 1,027,000 | 942,000 | 910,000 | 949,000 | 943,000 | 863,000 | 858,000 | 811,000 | 804,000 | 771,000 |
營業費用 | 568,000 | 543,000 | 524,000 | 563,000 | 505,000 | 517,000 | - | - | - | 471,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 530,000 | 506,000 | 487,000 | 524,000 | 466,000 | 478,000 | 460,000 | 449,000 | 420,000 | 442,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 38,000 | 37,000 | 37,000 | 39,000 | 39,000 | 39,000 | 37,000 | 32,000 | 29,000 | 29,000 |
營業利益 | 459,000 | 399,000 | 386,000 | 386,000 | 438,000 | 346,000 | 361,000 | 330,000 | 355,000 | 300,000 |
其他收入及費用 | 16,000 | -2,000 | 8,000 | 8,000 | 13,000 | -3,000 | 3,000 | 15,000 | 3,000 | 9,000 |
利息費用 | 63,000 | 63,000 | 64,000 | 66,000 | 67,000 | 67,000 | 65,000 | 49,000 | 44,000 | 43,000 |
稅前純益 | 412,000 | 334,000 | 330,000 | 328,000 | 384,000 | 276,000 | 299,000 | 296,000 | 314,000 | 266,000 |
所得稅 | 88,000 | 74,000 | 81,000 | 77,000 | 97,000 | 59,000 | 68,000 | 65,000 | 74,000 | 66,000 |
稅後純益 | 320,000 | 252,000 | 245,000 | 245,000 | 282,000 | 220,000 | 222,000 | 226,000 | 229,000 | 194,000 |
基本每股稅後盈餘(元) | 2.88 | 2.27 | 2.21 | 2.18 | 2.51 | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 |
稀釋每股稅後盈餘(元) | 2.84 | 2.24 | 2.18 | 2.16 | 2.47 | 1.94 | 1.95 | 1.99 | 2.03 | 1.72 |
基本平均股數(千股) | 111000.00 | 110000.00 | 111000.00 | 112000.00 | 112000.00 | 111000.00 | 111000.00 | 112000.00 | 111000.00 | 111000.00 |
稀釋平均股數(千股) | 112000.00 | 112000.00 | 112000.00 | 113000.00 | 113000.00 | 113000.00 | 113000.00 | 113000.00 | 112000.00 | 112000.00 |
還原基本每股稅後盈餘(元) | 2.88 | 2.27 | 2.21 | 2.18 | 2.51 | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 |
還原稀釋每股稅後盈餘(元) | 2.84 | 2.24 | 2.18 | 2.16 | 2.47 | 1.94 | 1.95 | 1.99 | 2.03 | 1.72 |
還原基本平均股數(千股) | 111,000 | 110,000 | 111,000 | 112,000 | 112,000 | 111,000 | 111,000 | 112,000 | 111,000 | 111,000 |
還原稀釋平均股數(千股) | 112,000 | 112,000 | 112,000 | 113,000 | 113,000 | 113,000 | 113,000 | 113,000 | 112,000 | 112,000 |
EBITDA(千元) | 617,000 | 536,000 | 535,000 | 530,000 | 589,000 | 486,000 | 490,000 | 465,000 | 464,000 | 419,000 |